These results demonstrated CD1d plays an important role in metabolic biological processes and signaling pathways in NAFLD progression, which may be useful to help identify clinical interventions for the treatment of hepatic steatosis. This evidence concerns the gene CD1D and metabolic dysfunction-associated steatotic liver disease.